These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35923472)

  • 1. Role of Nrf2 Signaling Pathway in the Radiation Tolerance of Patients with Head and Neck Squamous Cell Carcinoma: An in vivo and in vitro Study [Retraction].
    Onco Targets Ther; 2022; 15():827-828. PubMed ID: 35923472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Nrf2 signaling pathway in the radiation tolerance of patients with head and neck squamous cell carcinoma: an in vivo and in vitro study.
    Wang T; Hu P; Li B; Zhang JP; Cheng YF; Liang YM
    Onco Targets Ther; 2017; 10():1809-1819. PubMed ID: 28367064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYO5A Inhibition by miR-145 Acts as a Predictive Marker of Occult Neck Lymph Node Metastasis in Human Laryngeal Squamous Cell Carcinoma [Retraction].
    Onco Targets Ther; 2023; 16():729-730. PubMed ID: 37694106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Important Tumor Suppressor Role of
    Onco Targets Ther; 2023; 16():423-424. PubMed ID: 37359352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KIF4A Promotes Clear Cell Renal Cell Carcinoma (ccRCC) Proliferation in vitro and in vivo [Retraction].
    Onco Targets Ther; 2023; 16():309-310. PubMed ID: 37192931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-381 Enhances Radiosensitivity in Esophageal Squamous Cell Carcinoma by Targeting X-Linked Inhibitor of Apoptosis Protein [Retraction].
    Onco Targets Ther; 2023; 16():311-312. PubMed ID: 37197289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCNB1 Expedites the Progression of Cervical Squamous Cell Carcinoma via the Regulation by FOXM1 [Retraction].
    Onco Targets Ther; 2022; 15():1255-1256. PubMed ID: 36275181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA-493 Inhibits Tongue Squamous Cell Carcinoma Oncogenicity via Directly Targeting HMGA2 [Retraction].
    Onco Targets Ther; 2021; 14():4737-4738. PubMed ID: 34526777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LINC00152 Promotes the Growth and Invasion of Oral Squamous Cell Carcinoma by Regulating miR-139-5p [Retraction].
    Onco Targets Ther; 2021; 14():4297. PubMed ID: 34349521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-145 Inhibits the Activation of the mTOR Signaling Pathway to Suppress the Proliferation and Invasion of Invasive Pituitary Adenoma Cells by Targeting AKT3 in vivo and in vitro [Retraction].
    Onco Targets Ther; 2020; 13():6851. PubMed ID: 32764974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SNHG8 is Upregulated in Esophageal Squamous Cell Carcinoma and Directly Sponges microRNA-411 to Increase Oncogenicity by Upregulating KPNA2 [Retraction].
    Onco Targets Ther; 2021; 14():4993-4994. PubMed ID: 34785905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. lncRNA MAFG-AS1 Contributes to Esophageal Squamous-Cell Carcinoma Progression via Regulating miR143/LASP1 [Retraction].
    Onco Targets Ther; 2020; 13():12737. PubMed ID: 33335407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular Hsp90α Clinically Correlates with Tumor Malignancy and Promotes Migration and Invasion in Esophageal Squamous Cell Carcinoma [Retraction].
    Onco Targets Ther; 2020; 13():7353. PubMed ID: 32821118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations of Microvascular Blood Flow of Contrast-Enhanced Ultrasound and HGF/c-Met Signaling Pathway with Clinicopathological Features and Prognosis of Patients with Hepatocellular Carcinoma [Retraction].
    Onco Targets Ther; 2022; 15():1043-1044. PubMed ID: 36176729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-6/STAT3 Signaling Contributes to Sorafenib Resistance in Hepatocellular Carcinoma Through Targeting Cancer Stem Cells [Retraction].
    Onco Targets Ther; 2022; 15():871-872. PubMed ID: 36033902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of ERβ Participates in the Progression of Liver Cancer via Inhibiting the Notch Signaling Pathway [Retraction].
    Onco Targets Ther; 2020; 13():6849. PubMed ID: 32764973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Inhibitive Effect of sh-HIF1A-AS2 on the Proliferation, Invasion, and Pathological Damage of Breast Cancer via Targeting miR-548c-3p Through Regulating HIF-1α/VEGF Pathway in vitro and vivo [Retraction].
    Onco Targets Ther; 2021; 14():1003. PubMed ID: 33603405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-652 Suppresses Malignant Phenotypes in Glioblastoma Multiforme via FOXK1-Mediated AKT/mTOR Signaling Pathway [Retraction].
    Onco Targets Ther; 2021; 14():4935-4936. PubMed ID: 34611412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-126 Regulates Proliferation and Invasion in the Bladder Cancer BLS Cell Line by Targeting the PIK3R2-Mediated PI3K/Akt Signaling Pathway [Retraction].
    Onco Targets Ther; 2021; 14():1859. PubMed ID: 33732003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of Fibrous Sheath Interacting Protein 1 Expression Reduces Bladder Urothelial Carcinoma Cell Proliferation and Induces Apoptosis via Inhibition of the PI3K/AKT Pathway [Retraction].
    Onco Targets Ther; 2022; 15():85-86. PubMed ID: 35087278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.